Skip to lesson
OncoGuideeducationDiana’s wiki
THE EDUCATION LIBRARY

Cross-presentation

In one sentence

Cross-presentation occurs when a cell displays externally acquired antigen on class-I human leukocyte antigen molecules.

The intuition

A collector can show material made by another cell. This lets immune cells display fragments from a tumor they did not become. The analogy explains the antigen’s origin; it does not establish that the display activates a useful response.

How it works

Class-I human leukocyte antigen (HLA) commonly displays fragments from proteins made within the presenting cell. Cross-presentation instead routes material acquired from outside that cell onto class I. Dendritic cells can obtain tumor-derived material through this route.

Conventional type-1 dendritic cells are important cross-presenters in many settings. The underlying processing routes and contributions of other cells vary. Cross-presentation names a display process. Cross-priming names activation of naive CD8 T cells through that process, which requires supporting signals.

If a dendritic cell receives vaccine messenger RNA and makes the encoded protein itself, class-I display can be direct presentation. Antigen may also transfer between cells. It is inaccurate to assign every RNA vaccine exclusively to cross-presentation.

External tumor material Antigen acquired by presenting cell Class-I display: cross-presentation Supporting signals and matching naive cells Activation: cross-priming Antigen produced inside presenting cell Class-I direct presentation

Antigen origin distinguishes presentation routes; display and priming remain separate.

Why it matters in cancer

Cross-presentation can connect tumor-derived material to an adaptive response. It helps explain why the cells that initiate a response and the cells later attacked by that response are different.

Worked example

In a fictional experiment, a dendritic cell engulfs tumor debris and displays a tumor-derived peptide on class I. Cross-presentation is supported. If the experiment measures no naive T-cell activation, it has not yet established cross-priming. Display and activation require different readouts.

Common confusions

  • External antigen on class II is not cross-presentation merely because it came from outside.
  • Cross-presentation does not guarantee productive priming.
  • Direct presentation by a vaccine-transfected cell remains possible.

Sources and scope

Source check: October 8, 2026. This is a mechanism explanation, not a treatment recommendation. Expert and learner review remain pending.

Used in